Logo Image
Opinion|Videos|September 20, 2024

Current Advancements in Biomarker Research

The panel explores promising biomarker research that has the potential to significantly impact patient care in prostate cancer.

Episodes in this series

Video content above is prompted by the following question:

  • What current advancements in biomarker research are you most excited about? (Brian Richardson, MD)
    • Lysine-specific demethylase-1
    • Appl1, Sortilin, and Syndecan-1
    • Please highlight any others.

Related Content

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies
Multimedia

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

View more